AlphaFold predicted structure
MFSD2A · Q8NA29

Mean pLDDT
80.6/ 100
Confident
543 residues
Confidence breakdown
- Very high(≥ 90)48%
- Confident(70–90)32%
- Low(50–70)8%
- Very low(< 50)12%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
MFSD2 lysolipid transporter A, lysophospholipid
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
DDG2P
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalSevere microcephaly
BIALLELIC, autosomal or pseudoautosomalmicrocephaly 15, primary, autosomal recessive
autosomal recessive primary microcephaly
hereditary disease
Primary microcephaly
microcephaly
fetal growth restriction
Intellectual disability
Hyperammonemia
Delayed gross motor development
cryptorchidism
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Sodium-dependent lysophosphatidylcholine symporter 1
Sodium-dependent lysophosphatidylcholine (LPC) symporter, which plays an essential role for blood-brain barrier formation and function (PubMed:24828040, PubMed:32572202, PubMed:34135507). Specifically expressed in endothelium of the blood-brain barrier of micro-vessels and transports LPC into the brain (By similarity). Transport of LPC is essential because it constitutes the major mechanism by which docosahexaenoic acid (DHA), an omega-3 fatty acid that is essential for normal brain growth and cognitive function, enters the brain (PubMed:26005868, PubMed:34135507). Transports LPC carrying long-chain fatty acids such LPC oleate and LPC palmitate with a minimum acyl chain length of 14 carbons (By similarity). Does not transport docosahexaenoic acid in unesterified fatty acid (By similarity). Specifically required for blood-brain barrier formation and function, probably by mediating lipid transport (By similarity). Not required for central nervous system vascular morphogenesis (By similarity). Acts as a transporter for tunicamycin, an inhibitor of asparagine-linked glycosylation (PubMed:21677192). In placenta, acts as a receptor for ERVFRD-1/syncytin-2 and is required for trophoblast fusion (PubMed:18988732, PubMed:23177091)
MFSD2A · Q8NA29

Mean pLDDT
80.6/ 100
Confident
543 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0